Loading…
Reported covered position: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HALEON US HOLDINGS, LLC via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Regulation of and payment of over-the-counter drugs (OTC), including OTC switches.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHARLES RIVER LABORATORIES INTERNATIONAL, INC via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Source: Senate LDA
| PURDUE PHARMA LLP |
| 16 |
| 2022–2025 |
| BAUSCH HEALTH | 15 | 2023–2026 |
| CIGNA | 15 | 2023–2026 |
| CVS PREVIOUSLY AETNA | 15 | 2023–2026 |
| AMERICAN PODIATRIC MEDICAL ASSOCIATION | 14 | 2022–2025 |
| CLENE NANOMEDICINE | 14 | 2024–2026 |
| OCULAR THREPEUTIX | 14 | 2024–2026 |
| ELEVANCE HEALTH, INC. | 13 | 2023–2026 |
| UNITED NETWORK FOR ORGAN SHARING | 10 | 2024–2026 |
| ATEA PHARMACEUTICALS | 8 | 2022–2024 |
| CEDARS SINAI | 8 | 2025–2026 |
| GLOBAL MEDICAL RESPONSE | 8 | 2025–2026 |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 7 | 2022–2023 |
| GOODRX, INC. | 7 | 2025–2026 |
| COHERUS BIOSCIENCES, INC | 6 | 2022–2023 |
| HUMACYTE | 6 | 2025–2026 |
| BYHEART, INC. | 5 | 2025–2026 |
| HALEON US HOLDINGS, LLC | 5 | 2025–2026 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC | 4 | 2026 |
| ONE HEALTH PARTNERS | 4 | 2026 |
| DEROYAL INDUSTRIES INC | 3 | 2025–2026 |
| COMMUNICATIONS EATON CORPORATION | 1 | 2025 |
| JOHNSON CONTROLS INTERNATIONAL | 1 | 2025 |
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
ThinkDIFFERENTLY About Disability Employment Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Medicare and Medicaid payment policies. H.R.2542
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Organ Donation Referral Improvement Act
Client: UNITED NETWORK FOR ORGAN SHARING · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2025
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
A bill to amend title XVIII of the Social Security Act to provide Medicare coverage for all physicians' services furnished by doctors of chiropractic within the scope of their license, and for other purposes.
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Skinny Labels, Big Savings Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) · Firm: CAPITOL HILL CONSULTING GROUP
Issues S. 43, Skinny Labels, Big Savings Act.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
Issues surrounding hospital billing transparency including H.R. 3417 and S. 1869
Issues surrounding hospital billing transparency including H.R. 3417 and S. 1869
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860. Issues surrounding Medicare reimbursement of oral ESRD drugs.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860. Issues surrounding Medicare reimbursement of oral ESRD drugs.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the BETTER Kidney Care Act. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860. Issues surrounding Medicare reimbursement of oral ESRD drugs.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the BETTER Kidney Care Act. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860.
Medicare and Medicaid payment policies. H.R.8267 - Old Drugs, New Cures Act.
Medicare and Medicaid payment policies. H.R.8267 - Old Drugs, New Cures Act.
Medicare and Medicaid payment policies. H.R.8267 - Old Drugs, New Cures Act.
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act. Issues surrounding Medicare Advantage risk adjustment.
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act.
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act. Issues surrounding Medicare Advantage risk adjustment.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
Issues surrounding hospital billing transparency including H.R. 3417 and S. 1869
Issues surrounding hospital billing transparency including H.R. 3417 and S. 1869
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act. Issues surrounding Medicare Advantage risk adjustment.
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act.
Improving Seniors’ Timely Access to Care Act of 2024
Client: BETTER MEDICARE ALLIANCE · Firm: CAPITOL HILL CONSULTING GROUP
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding prior authorization including H.R.8702 and S.4532 the Improving Seniors Timely Access to Care Act. Issues surrounding Medicare Advantage risk adjustment.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2023
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R.1634. Expanded services through the Veterans Affairs Administration.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 1634. Expanded services through the Veterans Affairs Administration.
Resident Physician Shortage Reduction Act of 2023
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R.2389. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Resident Physician Shortage Reduction Act of 2023
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R.2389. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Resident Physician Shortage Reduction Act of 2023
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R.2389. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Resident Physician Shortage Reduction Act of 2023
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R.2389. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the BETTER Kidney Care Act. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement
Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ONE HEALTH PARTNERS via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Community Health Centers Funding, PACE Program. Issues relating to 340B drug pricing program.
Community Health Centers Funding, PACE Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HUMACYTE via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Issues related to Medicare reimbursement for biological products.
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOODRX, INC via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding ways to lower prescription drug costs. Issues related to direct to consumer access
Issues surrounding ways to lower prescription drug costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BYHEART, INC. via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CEDARS SINAI via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding federal medical research.
Issues relating to 340B drug pricing program. preparedness and response funding.
Issues surrounding federal medical research. Issues around federal hospital reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED NETWORK FOR ORGAN SHARING via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding the modernization of OPTN program
Issues surrounding organ transplantation including transportation of donated organs.
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
GLOBAL MEDICAL RESPONSE via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Medicare reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · 3T
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAUSCH HEALTH via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Pharmacy issues related to TRICARE.
Issues surrounding pharmacy benefit managers. Issues related to the No Surprises Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER MEDICARE ALLIANCE via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding Medicare Advantage risk adjustment, including home risk assessments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act. Issues related to generic drug review.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.
Issues related to potential tariffs on generic drugs.
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to TRICARE chiropractic coverage.
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to pharmacy benefit managers.
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER MEDICARE ALLIANCE via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding Medicare Advantage risk adjustment, including home risk assessments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HALEON US HOLDINGS, LLC via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Regulation of and payment of over-the-counter drugs (OTC), including OTC switches.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHARLES RIVER LABORATORIES INTERNATIONAL, INC via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ONE HEALTH PARTNERS via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Community Health Centers Funding, PACE Program
Community Health Centers Funding, PACE Program. Issues relating to 340B drug pricing program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HUMACYTE via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Issues related to Medicare reimbursement for biological products.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOODRX, INC via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding ways to lower prescription drug costs. Issues related to direct to consumer access
Issues surrounding ways to lower prescription drug costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CEDARS SINAI via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues relating to 340B drug pricing program. preparedness and response funding.
Issues surrounding federal medical research. Issues around federal hospital reimbursement
Issues surrounding federal medical research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED NETWORK FOR ORGAN SHARING via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding organ transplantation including transportation of donated organs.
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding the modernization of OPTN program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
GLOBAL MEDICAL RESPONSE via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Medicare reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAUSCH HEALTH via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment.
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Pharmacy issues related to TRICARE.
Issues surrounding pharmacy benefit managers. Issues related to the No Surprises Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act. Issues related to generic drug review.
Issues related to potential tariffs on generic drugs.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Issues related to TRICARE chiropractic coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to pharmacy benefit managers.
Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEROYAL INDUSTRIES, INC. via CAPITOL HILL CONSULTING GROUP
2026 · second_quarter · 2T
Medicare payment issues, appointment to Medicare Payment Advisory Commission (MedPAC)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BYHEART, INC. via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HALEON US HOLDINGS, LLC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Regulation of and payment of over-the-counter drugs (OTC), including OTC switches.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHARLES RIVER LABORATORIES INTERNATIONAL, INC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ONE HEALTH PARTNERS via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Community Health Centers Funding, PACE Program. Issues relating to 340B drug pricing program.
Community Health Centers Funding, PACE Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HUMACYTE via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to Medicare reimbursement for biological products.
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOODRX, INC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding ways to lower prescription drug costs.
Issues surrounding ways to lower prescription drug costs. Issues related to direct to consumer access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CEDARS SINAI via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues relating to 340B drug pricing program. preparedness and response funding.
Issues surrounding federal medical research.
Issues surrounding federal medical research. Issues around federal hospital reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED NETWORK FOR ORGAN SHARING via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding organ transplantation including transportation of donated organs.
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding the modernization of OPTN program
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
GLOBAL MEDICAL RESPONSE via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to Medicare reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAUSCH HEALTH via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act. Issues related to generic drug review.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.
Issues related to potential tariffs on generic drugs.
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to TRICARE chiropractic coverage.
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to pharmacy benefit managers.
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEROYAL INDUSTRIES, INC. via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Medicare payment issues, appointment to Medicare Payment Advisory Commission (MedPAC)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding pharmacy benefit managers, and coverage of biosimilars.
Pharmacy issues related to TRICARE.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER MEDICARE ALLIANCE via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · Q1
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding Medicare Advantage risk adjustment, including home risk assessments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES INTERNATIONAL, INC via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · RR
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
ONE HEALTH PARTNERS via CAPITOL HILL CONSULTING GROUP
2026 · first_quarter · RR
Community Health Centers Funding, PACE Programs.
Community Health Centers Funding, PACE Programs.
DEROYAL INDUSTRIES, INC. via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Medicare payment issues, appointment to Medicare Payment Advisory Commission (MedPAC)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BYHEART, INC. via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HALEON US HOLDINGS, LLC via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Regulation of and payment of over-the-counter drugs (OTC), including OTC switches.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BYHEART, INC. via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · RR
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
HALEON US HOLDINGS, LLC via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · RR
Regulation of and payment for over-the-counter drugs (OTC), including OTC switches.
HUMACYTE via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement for biological products.
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOODRX, INC via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding ways to lower prescription drug costs.
Issues surrounding ways to lower prescription drug costs. Issues related to direct to consumer access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CEDARS SINAI via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding federal medical research. Issues around federal hospital reimbursement
Issues surrounding federal medical research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED NETWORK FOR ORGAN SHARING via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding organ transplantation including transportation of donated organs. Issues surrounding H.R. 330
Issues surrounding organ transplantation including transportation of donated organs.
Issues surrounding organ transplantation including transportation of donated organs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Transportation, Dept of (DOT)
GLOBAL MEDICAL RESPONSE via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAUSCH HEALTH via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment.
Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Pharmacy issues related to TRICARE.
Issues surrounding pharmacy benefit managers, and coverage of biosimilars. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER MEDICARE ALLIANCE via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding Medicare Advantage Policy, including the annual Rate Notice; Issues surrounding Medicare Advantage risk adjustment, including home risk assessments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.
Issues related to potential tariffs on generic drugs.
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Medicare reimbursement and coverage of chiropractic services, including H.R.539 and S.106. Issues related to expanding access through telehealth. Issues related to physician reimbursement.
Issues related to TRICARE chiropractic coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · 4T
Issues related to potential tariffs on generic drugs.
Issues S. 43, Skinny Labels, Big Savings Act.
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act. - Issues related to biosimilars. - Issues related to drug shortages.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2025 · fourth_quarter · 4T
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; prescription drug payment reform; and pharmaceutical supply chain.
Monitored congressional efforts around the SACKLER Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMACYTE via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Payment for approved medical devices.
Payment for approved medical devices.
Payment for approved medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GOODRX, INC via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Issues surrounding ways to lower prescription drug costs.
Issues surrounding ways to lower prescription drug costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CEDARS SINAI via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Issues surrounding federal medical research. Issues around federal hospital reimbursement
Issues surrounding federal medical research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act.
Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform. Issues related to drug shortages
GLOBAL MEDICAL RESPONSE via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to Medicare reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCULAR THREPEUTIX via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to Medicare reimbursement for therapies of the eye.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Biopharmaceutical company focused on neurodegenerative diseases, including ALS. Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2025 · second_quarter · 2A
Biopharmaceutical company focused on neurodegenerative diseases, including ALS. Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLENE NANOMEDICINE via CAPITOL HILL CONSULTING GROUP
2025 · first_quarter · 1A
Biopharmaceutical company focused on neurodegenerative diseases, including ALS. Issues related to accelerated approval.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAUSCH HEALTH via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Issues surrounding Medicare and Medicaid coverage of prescription drugs, including H.R. 2542, the Old Drugs, New Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA via CAPITOL HILL CONSULTING GROUP
2025 · third_quarter · Q3
Pharmacy issues related to TRICARE.
Issues surrounding pharmacy benefit managers, and coverage of biosimilars. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to potential tariffs on generic drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE